Cover Image
Market Research Report
Product code 
1101968

LAMEA Peptide Therapeutics Market Size, Share & Industry Trends Analysis Report By Type (Innovative and Generic), By Route of Administration, By Synthesis Technology, By Type of Manufacturers, By Application, By Country and Growth Forecast, 2022 - 2028

Published: | KBV Research | 130 Pages | Delivery time: 1-2 business days

Price

Back to Top
LAMEA Peptide Therapeutics Market Size, Share & Industry Trends Analysis Report By Type (Innovative and Generic), By Route of Administration, By Synthesis Technology, By Type of Manufacturers, By Application, By Country and Growth Forecast, 2022 - 2028
Published: June 30, 2022
KBV Research
Content info: 130 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

The Latin America, Middle East and Africa Peptide Therapeutics Market would witness market growth of 12.5% CAGR during the forecast period (2022-2028).

O-glycosylation takes place in threonine or serine residues, where the oxygen molecule on the side chain forms an ether bond with the carbohydrate. Chemical glycosylation is a type of non-natural glycosylation that involves the binding of carbohydrate units to distinct amino acid residues at the peptide's N-terminus. Chemo-enzymatic glycosylation is another method of glycosylation that involves the use of enzymes. This approach is employed in the synthesis of complicated chemicals. Glycol-peptides and glycoproteins can be synthesized via chemical and chemo-enzymatic techniques. Cyclization can also be utilized to reduce proteolytic degradation and extend half-life by stiffening the peptide shape to prevent enzymatic cleavage.

AIDS, tuberculosis, malaria, gastroenteritis, and hypertension are the most common health concerns in Africa. According to the National Library of Medicines, hypertension affects nearly 20% of the adult population. Renal illness, particularly glomerular disease, is more common in Africa, and it appears to be more severe than in Western countries. The nephrotic syndrome is the most common manner of presentation, with onset between the ages of five and eight years. Renal-related symptoms account for 2 to 3% of overall medical admissions in tropical nations, with glomerulonephritides accounting for the bulk.

In all African countries, there are no accurate statistics on ESRD. The South African Dialysis and Transplant Registry (SADTR) statistics represent patients who have been approved for renal replacement therapy (RRT) rather than the etiology of chronic renal failure (CRF), as public sector state facilities would only provide RRT to patients who are transplant candidates.

The Brazil market dominated the LAMEA Peptide Therapeutics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,273.3 million by 2028. The Argentina market is poised to grow at a CAGR of 13.1% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 12.2% during (2022 - 2028).

Based on Type, the market is segmented into Innovative and Generic. Based on Route of Administration, the market is segmented into Parenteral Route, Pulmonary, Mucosal, Oral Route, and Others. Based on Synthesis Technology, the market is segmented into Liquid Phase Peptide Synthesis (LPPS), Solid Phase Peptide Synthesis (SPPS), and Hybrid Technology. Based on Type of Manufacturers, the market is segmented into In-house and Outsourced. Based on Application, the market is segmented into Metabolic, Cardiovascular Disorder, GIT & Renal, Antiinfection & Dermatology, Respiratory, Central Nervous System, Cancer, Pain, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Eli Lilly And Company, AstraZeneca PLC, Teva Pharmaceuticals Industries Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Lonza Group AG, and Amgen, Inc.

Scope of the Study

Market Segments covered in the Report:

By Type

  • Innovative
  • Generic

By Route of Administration

  • Parenteral Route
  • Pulmonary
  • Mucosal
  • Oral Route
  • Others

By Synthesis Technology

  • Liquid Phase Peptide Synthesis (LPPS)
  • Solid Phase Peptide Synthesis (SPPS)
  • Hybrid Technology

By Type of Manufacturers

  • In-house
  • Outsourced

By Application

  • Metabolic
  • Cardiovascular Disorder
  • GIT & Renal
  • Antiinfection & Dermatology
  • Respiratory
  • Central Nervous System
  • Cancer
  • Pain
  • Others

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

  • Eli Lilly And Company
  • AstraZeneca PLC
  • Teva Pharmaceuticals Industries Ltd.
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi S.A.
  • GlaxoSmithKline PLC
  • Takeda Pharmaceutical Company Limited
  • Lonza Group AG
  • Amgen, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.1 Objectives
  • 1.2 Market Scope
  • 1.3 Segmentation
    • 1.3.1 LAMEA Peptide Therapeutics Market, by Type
    • 1.3.2 LAMEA Peptide Therapeutics Market, by Route of Administration
    • 1.3.3 LAMEA Peptide Therapeutics Market, by Synthesis Technology
    • 1.3.4 LAMEA Peptide Therapeutics Market, by Type of Manufacturers
    • 1.3.5 LAMEA Peptide Therapeutics Market, by Application
    • 1.3.6 LAMEA Peptide Therapeutics Market, by Country
  • 1.4 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market composition and scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Acquisition and Mergers
    • 3.2.4 Approvals and Trails
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)

Chapter 4. LAMEA Peptide Therapeutics Market by Type

  • 4.1 LAMEA Innovative Market by Country
  • 4.2 LAMEA Generic Market by Country

Chapter 5. LAMEA Peptide Therapeutics Market by Route of Administration

  • 5.1 LAMEA Parenteral Route Market by Country
  • 5.2 LAMEA Pulmonary Market by Country
  • 5.3 LAMEA Mucosal Market by Country
  • 5.4 LAMEA Oral Route Market by Country
  • 5.5 LAMEA Others Market by Country

Chapter 6. LAMEA Peptide Therapeutics Market by Synthesis Technology

  • 6.1 LAMEA Liquid Phase Peptide Synthesis (LPPS) Market by Country
  • 6.2 LAMEA Solid Phase Peptide Synthesis (SPPS) Market by Country
  • 6.3 LAMEA Hybrid Technology Market by Country

Chapter 7. LAMEA Peptide Therapeutics Market by Type of Manufacturers

  • 7.1 LAMEA In-house Market by Country
  • 7.2 LAMEA Outsourced Market by Country

Chapter 8. LAMEA Peptide Therapeutics Market by Application

  • 8.1 LAMEA Metabolic Market by Country
  • 8.2 LAMEA Cardiovascular Disorder Market by Country
  • 8.3 LAMEA GIT & Renal Market by Country
  • 8.4 LAMEA Antiinfection & Dermatology Market by Country
  • 8.5 LAMEA Respiratory Market by Country
  • 8.6 LAMEA Central Nervous System Market by Country
  • 8.7 LAMEA Cancer Market by Country
  • 8.8 LAMEA Pain Market by Country
  • 8.9 LAMEA Others Market by Country

Chapter 9. LAMEA Peptide Therapeutics Market by Country

  • 9.1 Brazil Peptide Therapeutics Market
    • 9.1.1 Brazil Peptide Therapeutics Market by Type
    • 9.1.2 Brazil Peptide Therapeutics Market by Route of Administration
    • 9.1.3 Brazil Peptide Therapeutics Market by Synthesis Technology
    • 9.1.4 Brazil Peptide Therapeutics Market by Type of Manufacturers
    • 9.1.5 Brazil Peptide Therapeutics Market by Application
  • 9.2 Argentina Peptide Therapeutics Market
    • 9.2.1 Argentina Peptide Therapeutics Market by Type
    • 9.2.2 Argentina Peptide Therapeutics Market by Route of Administration
    • 9.2.3 Argentina Peptide Therapeutics Market by Synthesis Technology
    • 9.2.4 Argentina Peptide Therapeutics Market by Type of Manufacturers
    • 9.2.5 Argentina Peptide Therapeutics Market by Application
  • 9.3 UAE Peptide Therapeutics Market
    • 9.3.1 UAE Peptide Therapeutics Market by Type
    • 9.3.2 UAE Peptide Therapeutics Market by Route of Administration
    • 9.3.3 UAE Peptide Therapeutics Market by Synthesis Technology
    • 9.3.4 UAE Peptide Therapeutics Market by Type of Manufacturers
    • 9.3.5 UAE Peptide Therapeutics Market by Application
  • 9.4 Saudi Arabia Peptide Therapeutics Market
    • 9.4.1 Saudi Arabia Peptide Therapeutics Market by Type
    • 9.4.2 Saudi Arabia Peptide Therapeutics Market by Route of Administration
    • 9.4.3 Saudi Arabia Peptide Therapeutics Market by Synthesis Technology
    • 9.4.4 Saudi Arabia Peptide Therapeutics Market by Type of Manufacturers
    • 9.4.5 Saudi Arabia Peptide Therapeutics Market by Application
  • 9.5 South Africa Peptide Therapeutics Market
    • 9.5.1 South Africa Peptide Therapeutics Market by Type
    • 9.5.2 South Africa Peptide Therapeutics Market by Route of Administration
    • 9.5.3 South Africa Peptide Therapeutics Market by Synthesis Technology
    • 9.5.4 South Africa Peptide Therapeutics Market by Type of Manufacturers
    • 9.5.5 South Africa Peptide Therapeutics Market by Application
  • 9.6 Nigeria Peptide Therapeutics Market
    • 9.6.1 Nigeria Peptide Therapeutics Market by Type
    • 9.6.2 Nigeria Peptide Therapeutics Market by Route of Administration
    • 9.6.3 Nigeria Peptide Therapeutics Market by Synthesis Technology
    • 9.6.4 Nigeria Peptide Therapeutics Market by Type of Manufacturers
    • 9.6.5 Nigeria Peptide Therapeutics Market by Application
  • 9.7 Rest of LAMEA Peptide Therapeutics Market
    • 9.7.1 Rest of LAMEA Peptide Therapeutics Market by Type
    • 9.7.2 Rest of LAMEA Peptide Therapeutics Market by Route of Administration
    • 9.7.3 Rest of LAMEA Peptide Therapeutics Market by Synthesis Technology
    • 9.7.4 Rest of LAMEA Peptide Therapeutics Market by Type of Manufacturers
    • 9.7.5 Rest of LAMEA Peptide Therapeutics Market by Application

Chapter 10. Company Profiles

  • 10.1 Eli Lilly And Company
    • 10.1.1 Company Overview
    • 10.1.2 Financial Analysis
    • 10.1.3 Regional Analysis
    • 10.1.4 Research & Development Expenses
    • 10.1.5 Recent strategies and developments:
      • 10.1.5.1 Partnerships, Collaborations, and Agreements:
      • 10.1.5.2 Acquisition and Mergers:
      • 10.1.5.3 Approvals and Trails:
  • 10.2 AstraZeneca PLC
    • 10.2.1 Company Overview
    • 10.2.2 Financial Analysis
    • 10.2.3 Regional Analysis
    • 10.2.4 Research & Development Expenses
    • 10.2.5 Recent strategies and developments:
      • 10.2.5.1 Partnerships, Collaborations, and Agreements:
      • 10.2.5.2 Acquisition and Mergers:
  • 10.3 Teva Pharmaceutical Industries Ltd.
    • 10.3.1 Company Overview
    • 10.3.2 Financial Analysis
    • 10.3.3 Regional Analysis
    • 10.3.4 Research & Development Expenses
    • 10.3.5 Recent strategies and developments:
      • 10.3.5.1 Product Launches and Product Expansions:
      • 10.3.5.2 Approvals and Acquisitions:
  • 10.4 Novartis AG
    • 10.4.1 Company Overview
    • 10.4.2 Financial Analysis
    • 10.4.3 Segmental and Regional Analysis
    • 10.4.4 Research & Development Expense
    • 10.4.5 Recent strategies and developments:
      • 10.4.5.1 Acquisition and Mergers:
      • 10.4.5.2 Approvals and Trails:
  • 10.5 Pfizer, Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Financial Analysis
    • 10.5.3 Regional & Segmental Analysis
    • 10.5.4 Research & Development Expense
    • 10.5.5 Recent strategies and developments:
      • 10.5.5.1 Acquisition and Mergers:
  • 10.6 Sanofi S.A.
    • 10.6.1 Company Overview
    • 10.6.2 Financial Analysis
    • 10.6.3 Segmental and Regional Analysis
    • 10.6.4 Research & Development Expense
    • 10.6.5 Recent strategies and developments:
      • 10.6.5.1 Partnerships, Collaborations, and Agreements:
  • 10.7 GlaxoSmithKline PLC
    • 10.7.1 Company Overview
    • 10.7.2 Financial Analysis
    • 10.7.3 Segmental and Regional Analysis
    • 10.7.4 Research & Development Expense
  • 10.8 Takeda Pharmaceutical Company Limited
    • 10.8.1 Company Overview
    • 10.8.2 Financial Analysis
    • 10.8.3 Regional Analysis
    • 10.8.4 Research & Development Expense
    • 10.8.5 Recent strategies and developments:
      • 10.8.5.1 Partnerships, Collaborations, and Agreements:
      • 10.8.5.2 Approvals and Trails:
  • 10.9 Lonza Group AG
    • 10.9.1 Company Overview
    • 10.9.2 Financial Analysis
    • 10.9.3 Segmental and Regional Analysis
    • 10.9.4 Research & Development Expenses
  • 10.10. Amgen, Inc.
    • 10.10.1 Company Overview
    • 10.10.2 Financial Analysis
    • 10.10.3 Regional Analysis
    • 10.10.4 Research & Development Expenses
    • 10.10.5 Recent strategies and developments:
      • 10.10.5.1 Partnerships, Collaborations, and Agreements:

LIST OF TABLES

  • TABLE 1 LAMEA Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 2 LAMEA Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- Peptide Therapeutics Market
  • TABLE 4 Acquisition and Mergers- Peptide Therapeutics Market
  • TABLE 5 Approvals and trails- Peptide Therapeutics Market
  • TABLE 6 LAMEA Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 7 LAMEA Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 8 LAMEA Innovative Market by Country, 2018 - 2021, USD Million
  • TABLE 9 LAMEA Innovative Market by Country, 2022 - 2028, USD Million
  • TABLE 10 LAMEA Generic Market by Country, 2018 - 2021, USD Million
  • TABLE 11 LAMEA Generic Market by Country, 2022 - 2028, USD Million
  • TABLE 12 LAMEA Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 13 LAMEA Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 14 LAMEA Parenteral Route Market by Country, 2018 - 2021, USD Million
  • TABLE 15 LAMEA Parenteral Route Market by Country, 2022 - 2028, USD Million
  • TABLE 16 LAMEA Pulmonary Market by Country, 2018 - 2021, USD Million
  • TABLE 17 LAMEA Pulmonary Market by Country, 2022 - 2028, USD Million
  • TABLE 18 LAMEA Mucosal Market by Country, 2018 - 2021, USD Million
  • TABLE 19 LAMEA Mucosal Market by Country, 2022 - 2028, USD Million
  • TABLE 20 LAMEA Oral Route Market by Country, 2018 - 2021, USD Million
  • TABLE 21 LAMEA Oral Route Market by Country, 2022 - 2028, USD Million
  • TABLE 22 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 23 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 24 LAMEA Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 25 LAMEA Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 26 LAMEA Liquid Phase Peptide Synthesis (LPPS) Market by Country, 2018 - 2021, USD Million
  • TABLE 27 LAMEA Liquid Phase Peptide Synthesis (LPPS) Market by Country, 2022 - 2028, USD Million
  • TABLE 28 LAMEA Solid Phase Peptide Synthesis (SPPS) Market by Country, 2018 - 2021, USD Million
  • TABLE 29 LAMEA Solid Phase Peptide Synthesis (SPPS) Market by Country, 2022 - 2028, USD Million
  • TABLE 30 LAMEA Hybrid Technology Market by Country, 2018 - 2021, USD Million
  • TABLE 31 LAMEA Hybrid Technology Market by Country, 2022 - 2028, USD Million
  • TABLE 32 LAMEA Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 33 LAMEA Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 34 LAMEA In-house Market by Country, 2018 - 2021, USD Million
  • TABLE 35 LAMEA In-house Market by Country, 2022 - 2028, USD Million
  • TABLE 36 LAMEA Outsourced Market by Country, 2018 - 2021, USD Million
  • TABLE 37 LAMEA Outsourced Market by Country, 2022 - 2028, USD Million
  • TABLE 38 LAMEA Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 39 LAMEA Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 40 LAMEA Metabolic Market by Country, 2018 - 2021, USD Million
  • TABLE 41 LAMEA Metabolic Market by Country, 2022 - 2028, USD Million
  • TABLE 42 LAMEA Cardiovascular Disorder Market by Country, 2018 - 2021, USD Million
  • TABLE 43 LAMEA Cardiovascular Disorder Market by Country, 2022 - 2028, USD Million
  • TABLE 44 LAMEA GIT & Renal Market by Country, 2018 - 2021, USD Million
  • TABLE 45 LAMEA GIT & Renal Market by Country, 2022 - 2028, USD Million
  • TABLE 46 LAMEA Antiinfection & Dermatology Market by Country, 2018 - 2021, USD Million
  • TABLE 47 LAMEA Antiinfection & Dermatology Market by Country, 2022 - 2028, USD Million
  • TABLE 48 LAMEA Respiratory Market by Country, 2018 - 2021, USD Million
  • TABLE 49 LAMEA Respiratory Market by Country, 2022 - 2028, USD Million
  • TABLE 50 LAMEA Central Nervous System Market by Country, 2018 - 2021, USD Million
  • TABLE 51 LAMEA Central Nervous System Market by Country, 2022 - 2028, USD Million
  • TABLE 52 LAMEA Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 53 LAMEA Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 54 LAMEA Pain Market by Country, 2018 - 2021, USD Million
  • TABLE 55 LAMEA Pain Market by Country, 2022 - 2028, USD Million
  • TABLE 56 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 57 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 58 LAMEA Peptide Therapeutics Market by Country, 2018 - 2021, USD Million
  • TABLE 59 LAMEA Peptide Therapeutics Market by Country, 2022 - 2028, USD Million
  • TABLE 60 Brazil Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 61 Brazil Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 62 Brazil Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 63 Brazil Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 64 Brazil Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 65 Brazil Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 66 Brazil Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 67 Brazil Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 68 Brazil Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 69 Brazil Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 70 Brazil Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 71 Brazil Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 72 Argentina Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 73 Argentina Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 74 Argentina Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 75 Argentina Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 76 Argentina Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 77 Argentina Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 78 Argentina Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 79 Argentina Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 80 Argentina Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 81 Argentina Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 82 Argentina Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 83 Argentina Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 84 UAE Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 85 UAE Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 86 UAE Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 87 UAE Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 88 UAE Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 89 UAE Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 90 UAE Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 91 UAE Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 92 UAE Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 93 UAE Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 94 UAE Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 95 UAE Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 96 Saudi Arabia Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 97 Saudi Arabia Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 98 Saudi Arabia Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 99 Saudi Arabia Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 100 Saudi Arabia Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 101 Saudi Arabia Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 102 Saudi Arabia Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 103 Saudi Arabia Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 104 Saudi Arabia Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 105 Saudi Arabia Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 106 Saudi Arabia Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 107 Saudi Arabia Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 108 South Africa Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 109 South Africa Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 110 South Africa Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 111 South Africa Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 112 South Africa Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 113 South Africa Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 114 South Africa Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 115 South Africa Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 116 South Africa Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 117 South Africa Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 118 South Africa Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 119 South Africa Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 120 Nigeria Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 121 Nigeria Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 122 Nigeria Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 123 Nigeria Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 124 Nigeria Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 125 Nigeria Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 126 Nigeria Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 127 Nigeria Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 128 Nigeria Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 129 Nigeria Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 130 Nigeria Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 131 Nigeria Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 132 Rest of LAMEA Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 133 Rest of LAMEA Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 134 Rest of LAMEA Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 135 Rest of LAMEA Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 136 Rest of LAMEA Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 137 Rest of LAMEA Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 138 Rest of LAMEA Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 139 Rest of LAMEA Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 140 Rest of LAMEA Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 141 Rest of LAMEA Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 142 Rest of LAMEA Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 143 Rest of LAMEA Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 144 Key Information - Eli Lilly And Company
  • TABLE 145 KEY INFORMATION - ASTRAZENECA PLC
  • TABLE 146 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 147 Key Information - Novartis AG
  • TABLE 148 Key Information - Pfizer, Inc.
  • TABLE 149 Key Information - Sanofi S.A.
  • TABLE 150 Key Information - GlaxoSmithKline PLC
  • TABLE 151 Key Information - Takeda Pharmaceutical Company Limited
  • TABLE 152 Key Information - Lonza Group AG
  • TABLE 153 Key Information - Amgen, Inc.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
  • FIG 4 Recent strategies and developments: Eli Lilly And Company
  • FIG 5 Recent strategies and developments: AstraZeneca PLC
  • FIG 6 Recent strategies and developments: Teva Pharmaceuticals Industries Ltd.
  • FIG 7 Recent strategies and developments: Novartis AG